Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ENANTA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 15.7K | Mar 6, 2024 | Direct | ||
ALSP Orchid Acquisition Corp I | Director | No securities are beneficially owned | 0 | Nov 18, 2021 | Direct | ||
Mirati Therapeutics, Inc. | Director | Common Stock | 0 | $59.02 | Jan 23, 2024 | Direct | |
Mirati Therapeutics, Inc. | Director | Option to Purchase Common Stock | 0 | Jan 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ENTA | ENANTA PHARMACEUTICALS INC | Mar 6, 2024 | 1 | $0 | 4 | Mar 8, 2024 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 23, 2024 | 6 | $0 | 4 | Jan 23, 2024 | Director |
MRTX | Mirati Therapeutics, Inc. | Dec 29, 2023 | 1 | $400K | 4 | Jan 3, 2024 | Director |
ENTA | ENANTA PHARMACEUTICALS INC | Mar 2, 2023 | 1 | $0 | 4 | Mar 6, 2023 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 20, 2023 | 2 | $0 | 4 | Jan 24, 2023 | Director |
MRTX | Mirati Therapeutics, Inc. | Aug 12, 2022 | 4 | -$585K | 4 | Aug 16, 2022 | Director |
ENTA | ENANTA PHARMACEUTICALS INC | Mar 21, 2022 | 6 | -$253K | 4 | Mar 22, 2022 | Director |
ENTA | ENANTA PHARMACEUTICALS INC | Mar 3, 2022 | 1 | $0 | 4 | Mar 7, 2022 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 14, 2022 | 2 | $0 | 4 | Jan 18, 2022 | Director |
ALOR | ALSP Orchid Acquisition Corp I | Nov 18, 2021 | 0 | $0 | 3 | Nov 18, 2021 | Director |